REFERENCES
- Chin DP, Reingold AL, Stone EN, et al. The impact of Mycobacterium avium bacteremia and its treatment on sur-vival of AIDS patients - a prospective study. J Infect Dis 1994; 170: 578–84.
- Race EM, Adelson-Kitty J, Criegel GR, et al. Focal mycobacterial lymphoadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet, 1998; 351: 252–55.
- Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clar-ithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996; 335: 377–383.
- Chaisson RE, Benson CA, Dube MP, et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: a randomized, double-blind, dose ranging study in patients with AIDS. Ann Intern Med 1994; 121: 905–911.
- Pierce M, Crampton S, Henry D, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996; 335: 384–391.
- Havlir DV, Dube MP, Sattler FR, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin or both. N Engl J Med 1996; 335: 392–398.
- Soave R, Havlir D, Lancaster D, et al. Azithromycin therapy of AIDS-related cryptosporidial diarrhea. A multi-cen-ter, placebo controlled, double blind study. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy 1993 (Abstract 405).
- Chang HR. The potential role of azithromycin in the treatment or prophylaxis of toxoplasmosis. Int J Std AIDS 1996; 7 (Suppl 1): 18–22.